Immuno-oncology Drugs Market Report

China Immuno-oncology Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Aug 21, 2023
  • PAGES：171
  • REPORT CODE：GMM1747886
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Immuno-oncology Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • AbbVie, Inc

    • Prometheus Therapeutics & Diagnostics

    • Hoffmann-La Roche AG

    • Sanofi SA

    • Eli Lilly and Company

    • Bristol-Myers Squibb

    • Celgene Corporation

    • Amgen, Inc

    • Galena Biopharma

    • Novartis International AG

    • Aduro BioTech

    • AstraZeneca, Plc

    • Celldex Therapeutics

    • ImmunoCellular Therapeutics

    • Bavarian Nordic

    • Incyte

    • Gilead Sciences Inc

    • EMD Serono, Inc

    By Type:

    • Cancer Vaccines

    • CAR-T Cell Therapy

    • Monoclonal Antibodies

    • Cytokine-Based Immunotherapy

    • Immune Checkpoint Inhibitors

    By Application:

    • Online Pharmacies

    • Pharmacies

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Immuno-oncology Drugs Market Overview 2018-2029

    • 1.1 China Immuno-oncology Drugs Industry Development Overview

    • 1.2 China Immuno-oncology Drugs Industry Development History

    • 1.3 China Immuno-oncology Drugs Industry Market Size (2018-2029)

    • 1.4 China Immuno-oncology Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Immuno-oncology Drugs Production Volume, Production Value and Growth Rate of Cancer Vaccines (2018-2029)

      • 1.4.2 China Immuno-oncology Drugs Production Volume, Production Value and Growth Rate of CAR-T Cell Therapy (2018-2029)

      • 1.4.3 China Immuno-oncology Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

      • 1.4.4 China Immuno-oncology Drugs Production Volume, Production Value and Growth Rate of Cytokine-Based Immunotherapy (2018-2029)

      • 1.4.5 China Immuno-oncology Drugs Production Volume, Production Value and Growth Rate of Immune Checkpoint Inhibitors (2018-2029)

    • 1.5 China Immuno-oncology Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

      • 1.5.2 China Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate of Pharmacies (2018-2029)

      • 1.5.3 China Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Immuno-oncology Drugs Market Analysis by Region

      • 1.6.1 North China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Immuno-oncology Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Immuno-oncology Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Immuno-oncology Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Immuno-oncology Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Immuno-oncology Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Immuno-oncology Drugs Industry Development

    Chapter 3 Immuno-oncology DrugsIndustry Chain Analysis

    • 3.1 Immuno-oncology Drugs Industry Chain

    • 3.2 Immuno-oncology Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Immuno-oncology Drugs Market

    • 3.3 Immuno-oncology Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Immuno-oncology Drugs Market

    Chapter 4 China Immuno-oncology Drugs Market, by Type

    • 4.1 China Immuno-oncology Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Immuno-oncology Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Immuno-oncology Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Immuno-oncology Drugs Production Volume and Growth Rate of Cancer Vaccines

      • 4.5.2 China Immuno-oncology Drugs Production Volume and Growth Rate of CAR-T Cell Therapy

      • 4.5.3 China Immuno-oncology Drugs Production Volume and Growth Rate of Monoclonal Antibodies

      • 4.5.4 China Immuno-oncology Drugs Production Volume and Growth Rate of Cytokine-Based Immunotherapy

      • 4.5.5 China Immuno-oncology Drugs Production Volume and Growth Rate of Immune Checkpoint Inhibitors

    Chapter 5 China Immuno-oncology Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Immuno-oncology Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Immuno-oncology Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Immuno-oncology Drugs Market Size and Growth Rate of Online Pharmacies

      • 5.5.2 China Immuno-oncology Drugs Market Size and Growth Rate of Pharmacies

      • 5.5.3 China Immuno-oncology Drugs Market Size and Growth Rate of Hospitals

    Chapter 6 China Immuno-oncology Drugs Market, by Region

    • 6.1 China Immuno-oncology Drugs Production Volume and Production Value, by Region

    • 6.2 China Immuno-oncology Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Immuno-oncology Drugs Market Analysis

    • 7.1 North China Immuno-oncology Drugs Market, by Type

    • 7.2 North China Immuno-oncology Drugs Market, by Application

    Chapter 8 Central China Immuno-oncology Drugs Market Analysis

    • 8.1 Central China Immuno-oncology Drugs Market, by Type

    • 8.2 Central China Immuno-oncology Drugs Market, by Application

    Chapter 9 South China Immuno-oncology Drugs Market Analysis

    • 9.1 South China Immuno-oncology Drugs Market, by Type

    • 9.2 South China Immuno-oncology Drugs Market, by Application

    Chapter 10 East China Immuno-oncology Drugs Market Analysis

    • 10.1 East China Immuno-oncology Drugs Market, by Type

    • 10.2 East China Immuno-oncology Drugs Market, by Application

    Chapter 11 Northeast China Immuno-oncology Drugs Market Analysis

    • 11.1 Northeast China Immuno-oncology Drugs Market, by Type

    • 11.2 Northeast China Immuno-oncology Drugs Market, by Application

    Chapter 12 Southwest China Immuno-oncology Drugs Market Analysis

    • 12.1 Southwest China Immuno-oncology Drugs Market, by Type

    • 12.2 Southwest China Immuno-oncology Drugs Market, by Application

    Chapter 13 Northwest China Immuno-oncology Drugs Market Analysis

    • 13.1 Northwest China Immuno-oncology Drugs Market, by Type

    • 13.2 Northwest China Immuno-oncology Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 AbbVie, Inc

        • 14.1.1 AbbVie, Inc Company Profile

        • 14.1.2 AbbVie, Inc Immuno-oncology Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Prometheus Therapeutics & Diagnostics

        • 14.2.1 Prometheus Therapeutics & Diagnostics Company Profile

        • 14.2.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Hoffmann-La Roche AG

        • 14.3.1 Hoffmann-La Roche AG Company Profile

        • 14.3.2 Hoffmann-La Roche AG Immuno-oncology Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sanofi SA

        • 14.4.1 Sanofi SA Company Profile

        • 14.4.2 Sanofi SA Immuno-oncology Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Eli Lilly and Company

        • 14.5.1 Eli Lilly and Company Company Profile

        • 14.5.2 Eli Lilly and Company Immuno-oncology Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Bristol-Myers Squibb

        • 14.6.1 Bristol-Myers Squibb Company Profile

        • 14.6.2 Bristol-Myers Squibb Immuno-oncology Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Celgene Corporation

        • 14.7.1 Celgene Corporation Company Profile

        • 14.7.2 Celgene Corporation Immuno-oncology Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Amgen, Inc

        • 14.8.1 Amgen, Inc Company Profile

        • 14.8.2 Amgen, Inc Immuno-oncology Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Galena Biopharma

        • 14.9.1 Galena Biopharma Company Profile

        • 14.9.2 Galena Biopharma Immuno-oncology Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Novartis International AG

        • 14.10.1 Novartis International AG Company Profile

        • 14.10.2 Novartis International AG Immuno-oncology Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Aduro BioTech

        • 14.11.1 Aduro BioTech Company Profile

        • 14.11.2 Aduro BioTech Immuno-oncology Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 AstraZeneca, Plc

        • 14.12.1 AstraZeneca, Plc Company Profile

        • 14.12.2 AstraZeneca, Plc Immuno-oncology Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Celldex Therapeutics

        • 14.13.1 Celldex Therapeutics Company Profile

        • 14.13.2 Celldex Therapeutics Immuno-oncology Drugs Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 ImmunoCellular Therapeutics

        • 14.14.1 ImmunoCellular Therapeutics Company Profile

        • 14.14.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Bavarian Nordic

        • 14.15.1 Bavarian Nordic Company Profile

        • 14.15.2 Bavarian Nordic Immuno-oncology Drugs Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Incyte

        • 14.16.1 Incyte Company Profile

        • 14.16.2 Incyte Immuno-oncology Drugs Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Gilead Sciences Inc

        • 14.17.1 Gilead Sciences Inc Company Profile

        • 14.17.2 Gilead Sciences Inc Immuno-oncology Drugs Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 EMD Serono, Inc

        • 14.18.1 EMD Serono, Inc Company Profile

        • 14.18.2 EMD Serono, Inc Immuno-oncology Drugs Market Performance

        • 14.18.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Immuno-oncology Drugs Industry Research Conclusions

    • 15.2 Immuno-oncology Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Immuno-oncology Drugs Industry Market Size (2018-2029)

    • Figure China Immuno-oncology Drugs Production Volume, Production Value and Growth Rate of Cancer Vaccines (2018-2029)

    • Figure China Immuno-oncology Drugs Production Volume, Production Value and Growth Rate of CAR-T Cell Therapy (2018-2029)

    • Figure China Immuno-oncology Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

    • Figure China Immuno-oncology Drugs Production Volume, Production Value and Growth Rate of Cytokine-Based Immunotherapy (2018-2029)

    • Figure China Immuno-oncology Drugs Production Volume, Production Value and Growth Rate of Immune Checkpoint Inhibitors (2018-2029)

    • Figure China Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • Figure China Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate of Pharmacies (2018-2029)

    • Figure China Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Immuno-oncology Drugs Market Size and Growth Rate from 2018-2029

    • Figure Immuno-oncology Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Immuno-oncology Drugs Market Share by Type in 2018

    • Figure China Immuno-oncology Drugs Market Share by Type in 2023

    • Figure China Immuno-oncology Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Immuno-oncology Drugs Production Volume and Growth Rate of Cancer Vaccines (2018-2023)

    • Figure China Immuno-oncology Drugs Production Volume and Growth Rate of CAR-T Cell Therapy (2018-2023)

    • Figure China Immuno-oncology Drugs Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)

    • Figure China Immuno-oncology Drugs Production Volume and Growth Rate of Cytokine-Based Immunotherapy (2018-2023)

    • Figure China Immuno-oncology Drugs Production Volume and Growth Rate of Immune Checkpoint Inhibitors (2018-2023)

    • Figure China Immuno-oncology Drugs Market Share by Application in 2018

    • Figure China Immuno-oncology Drugs Market Share by Application in 2023

    • Figure China Immuno-oncology Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Immuno-oncology Drugs Market Size and Growth Rate of Online Pharmacies (2018-2023)

    • Figure China Immuno-oncology Drugs Market Size and Growth Rate of Pharmacies (2018-2023)

    • Figure China Immuno-oncology Drugs Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Immuno-oncology Drugs Production Volume by Region (2018-2023)

    • Table China Immuno-oncology Drugs Production Volume Share by Region (2018-2023)

    • Figure China Immuno-oncology Drugs Production Volume Share by Region (2018-2023)

    • Table China Immuno-oncology Drugs Production Value by Region (2018-2023)

    • Table China Immuno-oncology Drugs Production Value Share by Region (2018-2023)

    • Figure China Immuno-oncology Drugs Production Value Share by Region (2018-2023)

    • Table China Immuno-oncology Drugs Sales Volume by Region (2018-2023)

    • Table China Immuno-oncology Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Immuno-oncology Drugs Sales Volume Share by Region (2018-2023)

    • Table China Immuno-oncology Drugs Sales Value by Region (2018-2023)

    • Table China Immuno-oncology Drugs Sales Value Share by Region (2018-2023)

    • Figure China Immuno-oncology Drugs Sales Value Share by Region (2018-2023)

    • Table North China Immuno-oncology Drugs Production Volume by Type (2018-2023)

    • Table North China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Table North China Immuno-oncology Drugs Sales Volume by Application (2018-2023)

    • Table North China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Immuno-oncology Drugs Production Volume by Type (2018-2023)

    • Table Central China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Immuno-oncology Drugs Sales Volume by Application (2018-2023)

    • Table Central China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Immuno-oncology Drugs Production Volume by Type (2018-2023)

    • Table South China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Table South China Immuno-oncology Drugs Sales Volume by Application (2018-2023)

    • Table South China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Immuno-oncology Drugs Production Volume by Type (2018-2023)

    • Table East China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Table East China Immuno-oncology Drugs Sales Volume by Application (2018-2023)

    • Table East China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Immuno-oncology Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Immuno-oncology Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Immuno-oncology Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Immuno-oncology Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Immuno-oncology Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Immuno-oncology Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Immuno-oncology Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Immuno-oncology Drugs Sales Volume Share by Application (2018-2023)

    • Table AbbVie, Inc Company Profile

    • Table AbbVie, Inc Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Prometheus Therapeutics & Diagnostics Company Profile

    • Table Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Hoffmann-La Roche AG Company Profile

    • Table Hoffmann-La Roche AG Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Celgene Corporation Company Profile

    • Table Celgene Corporation Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Amgen, Inc Company Profile

    • Table Amgen, Inc Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Galena Biopharma Company Profile

    • Table Galena Biopharma Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis International AG Company Profile

    • Table Novartis International AG Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Aduro BioTech Company Profile

    • Table Aduro BioTech Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca, Plc Company Profile

    • Table AstraZeneca, Plc Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Celldex Therapeutics Company Profile

    • Table Celldex Therapeutics Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table ImmunoCellular Therapeutics Company Profile

    • Table ImmunoCellular Therapeutics Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Bavarian Nordic Company Profile

    • Table Bavarian Nordic Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Incyte Company Profile

    • Table Incyte Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences Inc Company Profile

    • Table Gilead Sciences Inc Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)

    • Table EMD Serono, Inc Company Profile

    • Table EMD Serono, Inc Immuno-oncology Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US